- Home
- IPSC vs RPTX Comparison
IPSC vs RPTX Comparison
Compare IPSC & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- RPTX
- Stock Information
- Founded
- IPSC 2019
- RPTX 2016
- Country
- IPSC United States
- RPTX Canada
- Employees
- IPSC 165
- RPTX N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- IPSC Health Care
- RPTX Health Care
- Exchange
- IPSC Nasdaq
- RPTX Nasdaq
- Market Cap
- IPSC 49.6M
- RPTX 63.9M
- IPO Year
- IPSC 2021
- RPTX 2020
- Fundamental
- Price
- IPSC $0.58
- RPTX $1.41
- Analyst Decision
- IPSC Strong Buy
- RPTX Strong Buy
- Analyst Count
- IPSC 5
- RPTX 3
- Target Price
- IPSC $3.33
- RPTX $4.50
- AVG Volume (30 Days)
- IPSC 868.9K
- RPTX 92.3K
- Earning Date
- IPSC 08-07-2025
- RPTX 08-05-2025
- Dividend Yield
- IPSC N/A
- RPTX N/A
- EPS Growth
- IPSC N/A
- RPTX N/A
- EPS
- IPSC N/A
- RPTX N/A
- Revenue
- IPSC $114,898,000.00
- RPTX $1,073,000.00
- Revenue This Year
- IPSC $1,064.82
- RPTX N/A
- Revenue Next Year
- IPSC N/A
- RPTX N/A
- P/E Ratio
- IPSC N/A
- RPTX N/A
- Revenue Growth
- IPSC 8286.72
- RPTX N/A
- 52 Week Low
- IPSC $0.34
- RPTX $0.89
- 52 Week High
- IPSC $3.29
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- IPSC 52.16
- RPTX 51.83
- Support Level
- IPSC $0.58
- RPTX $1.33
- Resistance Level
- IPSC $0.66
- RPTX $1.48
- Average True Range (ATR)
- IPSC 0.04
- RPTX 0.05
- MACD
- IPSC -0.00
- RPTX -0.01
- Stochastic Oscillator
- IPSC 41.52
- RPTX 34.37
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.